2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension

QR Code

2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension

Russian Society of Cardiology (RSC)With the participation: Association of Cardiovascular Surgeons of Russia, Russian Respiratory Society, Federation of Anesthesiologists and Resuscitators, Association of Rheumatologists of Russia, National Congress of Radiation Diagnosticians.

Saved in:

Bibliographic Details
Main Authors:	S. N. Avdeev, O. L. Barbarash, A. E. Bautin, A. V. Volkov, T. N. Veselova, A. S. Galyavich, N. S. Goncharova, S. V. Gorbachevsky, N. M. Danilov, A. A. Eremenko, T. V. Martynyuk, O. M. Moiseeva, M. A. Saidova, V. B. Sergienko, M. A. Simakova, O. V. Stukalova, I. E. Chazova, A. M. Chernyavsky, S. V. Shalaev, A. A. Shmalts, N. A. Tsareva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2022-01-01
Series:	Российский кардиологический журнал
Subjects:	pulmonary hypertension diagnosis risk stratification choice of optimal treatment tactics
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4683
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

2024 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension
by: S. N. Avdeev, et al.
Published: (2024-12-01)

EURASIAN CLINICAL GUIDELINES ON DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION
by: I. E. Chazova, et al.
Published: (2020-03-01)

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
by: A. A. Shmalts, et al.
Published: (2022-10-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023)
by: I. E. Chazova, et al.
Published: (2024-03-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020)
by: I. E. Chazova, et al.
Published: (2021-03-01)

CLINICAL CASE: COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: V. V. Bystrov, et al.
Published: (2014-12-01)

Corrected orthogonal vectorcardiography in pulmonary hypertension diagnostics
by: E. S. Yurasova, et al.
Published: (2005-12-01)

Calculation of hemodynamics by the Fick method in pulmonary hypertension associated with congenital heart defects
by: A. A. Shmalts, et al.
Published: (2022-05-01)

INFLUENCE OF PULMONARY HYPERTENSION ON CLINICAL COURSE AND PROGNOSIS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: S. N. Avdeev, et al.
Published: (2018-07-01)

CLINICAL CASE: THERAPY WITH SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2015-12-01)

FEATURES OF PULMONARY ARTERIAL HYPERTENSION IN THE RUSSIAN REGISTER
by: O. A. Arkhipova, et al.
Published: (2014-12-01)

CLINICAL CASE OF SUCCESSFUL 10-YEAR AMBRIZENTAN TREATMENT OF THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
by: T. V. Martynyuk, et al.
Published: (2015-12-01)

CONTEMPORARY STRATEGY OF PULMONARY HYPERTENSION MANAGEMENT IN PEDIATRICS
by: I. M. Miklashevich, et al.
Published: (2018-04-01)

SUCCESSFUL TREATMENT OF INOPERABLE THROMBOEMBOLIC PULMONARY HYPERTENSION PATIENT WITH SILDENAFIL IN HIGH DOSES
by: Z. H. Dadacheva, et al.
Published: (2014-12-01)

CARDIOPULMONARY EXCERSISE TESTING IN RISK STRATIFICATION IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: I. N. Taran, et al.
Published: (2017-12-01)

PULMONARY ARTERIAL HYPERTENSION DIAGNOSTICS SPECIFICS IN SYSTEMIC SCLERODERMIA
by: M. A. Simakova, et al.
Published: (2016-11-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

Principles of healthcare management for patients with pulmonary hypertension: focus on continuity
by: V. A. Ryabkov, et al.
Published: (2023-03-01)

PULMONARY VENTILATION AND GAS EXCHANGE EFFICIENCY IN RISK ASSESSMENT FOR CHRONIC POSTTHROMBOEMBOLIC PULMONARY HYPERTENSION
by: I. Yu. Loginova, et al.
Published: (2017-10-01)

MANAGEMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE PANDEMIC OF A NEW CORONAVIRUS INFECTION
by: T. V. Martynyuk, et al.
Published: (2020-06-01)

PERFUSION LUNG SCINTIGRAPHY IN PATIENTS WITH A PULMONARY HYPERTENSION OF A VARIOUS ETIOLOGY
by: O. A. Arkhipova, et al.
Published: (2015-12-01)

APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFIL IN PATIENTS WITH PULMONARY HYPERTENSION
by: T. V. Martynyuk, et al.
Published: (2015-06-01)

Pulmonary arterial hypertension: challenges and achievements 2021
by: E. A. Rezukhina, et al.
Published: (2022-03-01)

Russian consensus: balloon pulmonary angioplasty in treatment of chronic thromboembolic pulmonary hypertension
by: N. M. Danilov, et al.
Published: (2025-03-01)

SEARCH FOR CLINICAL PREDICTORS OF PULMONARY HYPERTENSION IN PATIENTS WITH SYSTEMIC SCLEROSIS
by: N. A. Klyaus, et al.
Published: (2018-11-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)
by: I. E. Chazova, et al.
Published: (2022-05-01)

ATOMIC FORCE MICROSCOPY OF NEUTROPHILS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH PULMONARY HYPERTENSION
by: V. V. Gaynitdinova, et al.
Published: (2016-12-01)

Tissue myocardial Doppler echocardiography in the assessment of right ventricular function among patients with pulmonary hypertension of various aetiology
by: Yu. A. Andreeva, et al.
Published: (2010-04-01)

CLINICAL CASE: OPPORTUNITY OF THERAPY OPTIMIZATION DUE TO TRANSITIONING FROM SILDENAFIL TO RIOCIGUAT IN PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: I. N. Taran, et al.
Published: (2016-12-01)

CLINICAL FEATURES OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL SYSTEMIC-TO-PULMONARYSHUNTS
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

Treatment Strategy Options in Inoperable Chronic Thromboembolic Pulmonary Hypertension Patients
by: N. V. Marukyan, et al.
Published: (2021-05-01)

New perspectives in pulmonary arterial hypertension treatment: 2009 European recommendations
by: T. V. Martynyuk, et al.
Published: (2010-04-01)

CLINICAL CASE OF COMBINATION THERAPY INCLUDING AMBRIZENTAN IN THE PATIENT WITH SEVERE IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
by: G. A. Movsisyan, et al.
Published: (2017-06-01)

COMPLICATED CLINICAL CASE: CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION IN PATIENT WITH RECIDIVOUS CARDIAC MYXOMA
by: A. M. Zykova, et al.
Published: (2018-03-01)

Cardiopulmonary exercise testing in patients with precapillary pulmonary hypertension with an unfavorable prognosis
by: A. V. Berezina, et al.
Published: (2024-10-01)

NEW APPROACH OF QUANTITATIVE NUCLEAR CARDIAC PERFUSION ASSESSMENT IN PATIENTS WITH PULMONARY HYPERTENSION
by: A. A. Ansheles, et al.
Published: (2017-01-01)

Pulmonary hypertension associated with portal hypertension and pulmonary hypertension in sarcoididosis of breathing organs: complex pathogenetic relationships
by: T. P. Kalacheva, et al.
Published: (2018-12-01)

CLINICAL AND HEMODYNAMIC PROFILE AND NEUROHORMONAL INDICATORS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION, DEPENDING ON VASOREACTIVITY RESERVE OF PULMONARY ARTERIES
by: V. M. Paramonov, et al.
Published: (2016-03-01)

OPTIMIZATION OF SPECIFIC THERAPY FOR PULMONARY ARTERIAL HYPERTENSION: THE POSSIBILITIES OF USING ENDOTHELIN RECEPTOR ANTAGONISTS
by: T. V. Martynyuk, et al.
Published: (2017-06-01)

EXPERIENCE OF USING THE NONSELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
by: M. A. Simakova, et al.
Published: (2018-04-01)